Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Endocrinology
Advanced Heart Failure and Transplant
Questions discussed in this category
How many days prior to surgery do you recommend stopping SGLT2 inhibitors and when is it safe to resume therapy?
1 Answer available
Are recurrent UTIs a contraindication to SGLT2i use?
4 Answers available
Is there enough evidence now to use injectable semaglutide as a foundational therapy for symptomatic heart failure with preserved ejection fraction in the setting of overweight or obesity?
1 Answer available
21415
19804
18168
Papers discussed in this category
The New England journal of medicine, 2023 Aug 25
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
Related Topics in Endocrinology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Genitourinary Cancers
Melanoma/Skin Cancer